Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery

NCT06185829 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-12-09

No results posted yet for this study

Summary

This is a single-center, prospective, randomized, open-label study of two parallel groups of patients undergoing hand surgery:

Group 1: locoregional anesthesia + neuroleptanalgesia Group 2: locoregional anesthesia + hypnoanalgesia Therapeutic benefit is based on VAS assessment of intraoperative anxiety.

Conditions

  • Hand Surgery

Interventions

DRUG

Neuroleptanalgesic treatment

Usual neuroleptanalgesic treatment Hypnovel and Locoregional anesthesia

OTHER

Hypnoanalgesia

Hypnoanalgesia and Locoregional anesthesia

Sponsors & Collaborators

  • Vivactis M2Research

    collaborator INDUSTRY
  • GCS Ramsay Santé pour l'Enseignement et la Recherche

    lead OTHER

Principal Investigators

  • Mélanie FROMENTIN, MD · Hôpital Privé Paul d'Egine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-19
Primary Completion
2026-11-30
Completion
2027-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06185829 on ClinicalTrials.gov